These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28125604)

  • 1. Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
    Lorin J; Guilland JC; Stamboul K; Guenancia C; Cottin Y; Rochette L; Vergely C; Zeller M
    PLoS One; 2017; 12(1):e0169979. PubMed ID: 28125604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
    Mommersteeg PM; Schoemaker RG; Eisel UL; Garrelds IM; Schalkwijk CG; Kop WJ
    Psychosom Med; 2015 Apr; 77(3):292-302. PubMed ID: 25790241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M; Korandji C; Guilland JC; Sicard P; Vergely C; Lorgis L; Beer JC; Duvillard L; Lagrost AC; Moreau D; Gambert P; Cottin Y; Rochette L
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
    Korandji C; Zeller M; Guilland JC; Vergely C; Sicard P; Duvillard L; Gambert P; Moreau D; Cottin Y; Rochette L
    Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
    Brooks ER; Langman CB; Wang S; Price HE; Hodges AL; Darling L; Yang AZ; Smith FA
    Pediatr Nephrol; 2009 Jan; 24(1):129-34. PubMed ID: 18830716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
    Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P
    Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.
    Lorin J; Guilland JC; Korandji C; Touzery C; Bichat F; Chagnon A; Cottin Y; Rochette L; Vergely C; Zeller M
    PLoS One; 2013; 8(6):e64796. PubMed ID: 23755144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
    Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M
    Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
    Lüneburg N; von Holten RA; Töpper RF; Schwedhelm E; Maas R; Böger RH
    Clin Sci (Lond); 2012 Feb; 122(3):105-11. PubMed ID: 21777201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
    Speranza L; Franceschelli S; D'Orazio N; Gaeta R; Bucciarelli T; Felaco M; Grilli A; Riccioni G
    Microvasc Res; 2011 Nov; 82(3):391-6. PubMed ID: 21722652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
    Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.